Ignite Creation Date:
2025-12-25 @ 3:53 AM
Ignite Modification Date:
2026-01-29 @ 3:18 AM
Study NCT ID:
NCT02955602
Status:
COMPLETED
Last Update Posted:
2022-07-14
First Post:
2016-11-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Seladelpar (MBX-8025) in Subjects With Primary Biliary Cholangitis (PBC)
Sponsor:
Gilead Sciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-11-28
Start Date Type:
ACTUAL
Primary Completion Date:
2018-09-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-07-08
Completion Date Type:
ACTUAL
First Submit Date:
2016-11-02
First Submit QC Date:
None
Study First Post Date:
2016-11-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-03-21
Results First Submit QC Date:
None
Results First Post Date:
2022-07-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-06-21
Last Update Post Date:
2022-07-14
Last Update Post Date Type:
ACTUAL